Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011–2023 †.

MLA

Romanelli, Maria Novella, et al. “Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011–2023 †.” Molecules, vol. 29, no. 1, Jan. 2024, p. 68. EBSCOhost, https://doi.org/10.3390/molecules29010068.

APA

Romanelli, M. N., Braconi, L., Gabellini, A., Manetti, D., Marotta, G., & Teodori, E. (2024). Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011–2023 †. Molecules, 29(1), 68. https://doi.org/10.3390/molecules29010068

Chicago

Romanelli, Maria Novella, Laura Braconi, Alessio Gabellini, Dina Manetti, Giambattista Marotta, and Elisabetta Teodori. 2024. “Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011–2023 †.” Molecules 29 (1): 68. doi:10.3390/molecules29010068.